Skip to content

AORT · NYSE

Artivion (AORT) Stock Price & Fundamentals

$316.98−0.44%−$1.39End-of-day price as of Oct 9, 2026

Artivion (AORT) closed at $316.98 on Oct 9, 2026, down 0.44% from the previous close of $318.37.

Share price, past year

1Y −11.25%

52-week range $288.77 – $357.18. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$316.98
Sep 30, 2026$309.65
Aug 31, 2026$329.55
Jul 31, 2026$323.21
Jun 30, 2026$336.75
May 29, 2026$334.23
Apr 30, 2026$317.36
Mar 31, 2026$293.03
Feb 27, 2026$303.50
Jan 30, 2026$321.56
Dec 31, 2025$325.66
Nov 28, 2025$341.11
Oct 31, 2025$342.99

Key statistics

Market cap
$15.45B
P/E (TTM)
—
EPS (TTM)
−$0.06
Revenue (TTM)
$471.47M
Net income (TTM)
−$3.17M
Shares outstanding
48.8M
Dividend yield
—
52-week range
$288.77 – $357.18

Artivion's market cap is $15.45B, based on a share price of $316.98 and 48.8M shares outstanding as of Jul 31, 2026.

Financials

Artivion reported revenue of $441.33M for fiscal 2025, up 13.59% from fiscal 2024.

Artivion earned net income of $9.77M in fiscal 2025, a net margin of 2.2%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Artivion annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$441.33M+13.6%$9.77M2.2%$0.21$839.00K
FY2024ended Dec 31, 2024$388.54M+9.8%−$13.36M−3.4%−$0.32$11.05M
FY2023ended Dec 31, 2023$354.00M+12.8%−$30.69M−8.7%−$0.75$9.07M
FY2022ended Dec 31, 2022$313.79M+5.0%−$19.19M−6.1%−$0.48−$15.87M
FY2021ended Dec 31, 2021$298.84M+18.0%−$14.83M−5.0%−$0.38−$15.68M
FY2020ended Dec 31, 2020$253.23M−8.3%−$16.68M−6.6%−$0.44$5.04M
FY2019ended Dec 31, 2019$276.22M+5.1%$1.72M0.6%$0.05$7.76M
FY2018ended Dec 31, 2018$262.84M+38.6%−$2.84M−1.1%−$0.08$4.10M
FY2017ended Dec 31, 2017$189.70M+5.2%$3.70M2.0%$0.11$4.17M
FY2016ended Dec 31, 2016$180.38M—$10.78M6.0%$0.32$13.52M
Artivion quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$125.76M−$13.51M−$0.28
Q1 FY2026ended Mar 31, 2026$116.34M$1.42M$0.03
Q4 FY2025ended Dec 31, 2025$115.99M$2.43M$0.06
Q3 FY2025ended Sep 30, 2025$113.39M$6.50M$0.13
Q2 FY2025ended Jun 30, 2025$112.97M$1.35M$0.03
Q1 FY2025ended Mar 31, 2025$98.98M−$505.00K−$0.01
Q4 FY2024ended Dec 31, 2024$97.31M−$16.48M−$0.40
Q3 FY2024ended Sep 30, 2024$95.78M−$2.29M−$0.05

Company profile

Name
Artivion, Inc.
Ticker
AORT
Exchange
NYSE
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
1655 Roberts Boulevard N W, Kennesaw, GA 30144
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000784199

Recent SEC filings

Frequently asked questions

What is Artivion's stock price?

Artivion (AORT) closed at $316.98 on Oct 9, 2026, down 0.44% from the previous close of $318.37.

What is Artivion's market cap?

Artivion's market cap is $15.45B, based on a share price of $316.98 and 48.8M shares outstanding as of Jul 31, 2026.

How much revenue does Artivion make?

Artivion reported revenue of $441.33M for fiscal 2025, up 13.59% from fiscal 2024.

Does Artivion pay a dividend?

Artivion's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Artivion, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures